3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Burkitt Lymphoma
7
Leukemia, Myeloid, Acute
4
Myelodysplastic Syndromes
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia, Biphenotypic, Acute
2
Leukemia
2
Down Syndrome
2
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Lymphoma
1
Interventions
fludarabine
5
Cyclophosphamide
5
fludarabine phosphate
4
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Mesna
2
Melphalan
2
Busulfan
2
Bendamustine Hydrochloride
2
AP 1903 reagent
2
pembrolizumab
1
isatuximab
1
ibrutinib
1
Lenalidomide
1
Dexamethasone
1
CLR1404
1
CA-4948
1
Bortezomib
1
Bone Marrow Transplantation
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoproliferative Disorders
×
asparaginase erwinia chrysanthemi recombinant
×
1 year
×
Clear all
No trials found.